ERBB2 and breast cancer: The overexpression of the human epidermal growth factor receptor (HER) 2 protein, commonly known as HER2-positive BC, is present in approximately 20–25% of BC cases and is associated with worse prognosis and, consequently, overall survival (OS) [4].